Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 64,530 | 1,750 | 1,750 | 9,750 | 1,750 |
| Gross Profit | 64,530 | 1,750 | 1,750 | 9,750 | 1,750 |
| Operating Expenses | 62,978 | 47,125 | 30,150 | 27,277 | 24,999 |
| Operating Income | 1,552 | -45,375 | -28,400 | -17,527 | -23,249 |
| Other Income | 270 | 301 | 647 | 929 | 897 |
| Pre-tax Income | 1,822 | -45,074 | -27,753 | -16,598 | -22,352 |
| Net Income Continuous | 1,822 | -45,074 | -27,753 | -16,598 | -22,352 |
| Net Income | $1,822 | $-45,074 | $-27,753 | $-16,598 | $-22,352 |
| EPS Basic Total Ops | 0.03 | -0.93 | -0.63 | -0.37 | -0.51 |
| EPS Basic Continuous Ops | 0.03 | -0.93 | -0.63 | -0.38 | -0.51 |
| EPS Diluted Total Ops | 0.03 | -0.93 | -0.63 | -0.37 | -0.51 |
| EPS Diluted Continuous Ops | 0.03 | -0.93 | -0.63 | -0.38 | -0.51 |
| EBITDA(a) | $2,542 | $-44,513 | $-27,662 | $-17,096 | $-22,996 |